# Commercialization Gate Status

**Date:** 2026-09-06
**Current state:** `OPEN_VALIDATION`
**Decision owner:** Mike Holownych

## Current evidence

- Revenue: `$0`
- Attributable payments: `0`
- five-paying-customer threshold: unmet
- Attributable paid-client case study: none
- There is no attributable paid-client case study.
- Stamped production audits: not verified at the 500-audit threshold
- Observatory observation period: the required 14-day period is not verified as satisfied

These are current governance facts for decision-making. They are not a customer-outcome claim.

## Gate definitions

### `OPEN_VALIDATION`

Use while the evidence needed for commercialization review is incomplete. This is the current state.

### `READY_FOR_REVIEW`

May be used only when `payment_count > 0`, the relevant stamped-audit and observation-period evidence is present, and the case-study and consent review inputs are available. A zero-payment state cannot be `READY_FOR_REVIEW`: `payment_count == 0` is always ineligible.

### `GATED`

Use when a reviewed decision explicitly permits the next capability or ICP expansion after the required evidence is complete.

## Prohibited expansion while open

While the state is `OPEN_VALIDATION`:

- signal expansion is prohibited until the 500 stamped audits and 14-day observatory requirement are actually met and reviewed;
- ICP expansion is prohibited until the five paying customers decision gate is met or explicitly revised;
- founders must not be expanded to agencies or pre-launch teams as a product strategy based on theory alone;
- no new public benchmark rate, case study, testimonial, or outcome claim may be created from this record; and
- a reply, audit, checkout click, or booked conversation cannot substitute for an attributable payment.

## Transition rule

The state may move from `OPEN_VALIDATION` to `READY_FOR_REVIEW` only after a reviewer confirms nonzero attributable payments and the other required evidence. It may move to `GATED` only after the review decision is recorded with scope, evidence references, and explicit authorization.
